290 related articles for article (PubMed ID: 15036005)
1. Mutagens formed from beta-carbolines with aromatic amines.
Totsuka Y; Takamura-Enya T; Nishigaki R; Sugimura T; Wakabayashi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):135-41. PubMed ID: 15036005
[TBL] [Abstract][Full Text] [Related]
2. Biological significance of aminophenyl-β-carboline derivatives formed from co-mutagenic action of β-carbolines and aniline and o-toluidine and its effect on tumorigenesis in humans: A review.
Totsuka Y; Wakabayashi K
Mutat Res Genet Toxicol Environ Mutagen; 2020; 850-851():503148. PubMed ID: 32247557
[TBL] [Abstract][Full Text] [Related]
3. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
[TBL] [Abstract][Full Text] [Related]
4. Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains.
Oda Y; Totsuka Y; Wakabayashi K; Guengerich FP; Shimada T
Mutagenesis; 2006 Nov; 21(6):411-6. PubMed ID: 17067997
[TBL] [Abstract][Full Text] [Related]
5. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.
Totsuka Y; Hada N; Matsumoto K; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
Carcinogenesis; 1998 Nov; 19(11):1995-2000. PubMed ID: 9855015
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats.
Kawamori T; Totsuka Y; Uchiya N; Kitamura T; Shibata H; Sugimura T; Wakabayashi K
Carcinogenesis; 2004 Oct; 25(10):1967-72. PubMed ID: 15142889
[TBL] [Abstract][Full Text] [Related]
8. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline.
Ohe T; Takata T; Maeda Y; Totsuka Y; Hada N; Matsuoka A; Tanaka N; Wakabayashi K
Mutat Res; 2002 Mar; 515(1-2):181-8. PubMed ID: 11909766
[TBL] [Abstract][Full Text] [Related]
9. Structure of DNA adduct formed with aminophenylnorharman, being responsible for the comutagenic action of norharman with aniline.
Totsuka Y; Takamura-Enya T; Kawahara N; Nishigaki R; Sugimura T; Wakabayashi K
Chem Res Toxicol; 2002 Oct; 15(10):1288-94. PubMed ID: 12387627
[TBL] [Abstract][Full Text] [Related]
10. Testicular toxicity in F344 rats by aminophenylnorharman, formed from norharman and aniline.
Totsuka Y; Kawamori T; Hisada S; Mitsumori K; Ishihara J; Sugimura T; Wakabayashi K
Toxicol Appl Pharmacol; 2001 Sep; 175(2):169-75. PubMed ID: 11543649
[TBL] [Abstract][Full Text] [Related]
11. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse.
Masumura K; Totsuka Y; Wakabayashi K; Nohmi T
Carcinogenesis; 2003 Dec; 24(12):1985-93. PubMed ID: 12970073
[TBL] [Abstract][Full Text] [Related]
12. Detection of aminophenylnorharman, a possible endogenous mutagenic and carcinogenic compound, in human urine samples.
Nishigaki R; Totsuka Y; Kataoka H; Ushiyama H; Goto S; Akasu T; Watanabe T; Sugimura T; Wakabayashi K
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):151-6. PubMed ID: 17220344
[TBL] [Abstract][Full Text] [Related]
13. Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline.
Nishigaki R; Totsuka Y; Takamura-Enya T; Sugimura T; Wakabayashi K
Mutat Res; 2004 Aug; 562(1-2):19-25. PubMed ID: 15279827
[TBL] [Abstract][Full Text] [Related]
14. Identification of the major hepatic DNA adduct formed by the food mutagen 2-amino-9H-pyrido[2,3-b]indole (A alpha C).
Pfau W; Schulze C; Shirai T; Hasegawa R; Brockstedt U
Chem Res Toxicol; 1997 Oct; 10(10):1192-7. PubMed ID: 9348443
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of DNA adducts of two heterocyclic amines, 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAalphaC) and 2-amino-9H-pyrido[2,3-b]indole (AalphaC) and identification of DNA adducts in organs from rats dosed with MeAalphaC.
Frederiksen H; Frandsen H; Pfau W
Carcinogenesis; 2004 Aug; 25(8):1525-33. PubMed ID: 15059926
[TBL] [Abstract][Full Text] [Related]
16. Identification of new mutagenic heterocyclic amines and quantification of known heterocyclic amines.
Wakabayashi K; Kim IS; Kurosaka R; Yamaizumi Z; Ushiyama H; Takahashi M; Koyota S; Tada A; Nukaya H; Goto S
Princess Takamatsu Symp; 1995; 23():39-49. PubMed ID: 8844794
[TBL] [Abstract][Full Text] [Related]
17. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
[TBL] [Abstract][Full Text] [Related]
18. Analysis of an RNA adduct formed from aminophenylnorharman.
Nishimura K; Totsuka Y; Higuchi T; Kawahara N; Sugimura T; Wakabayashi K
Nucleic Acids Symp Ser (Oxf); 2009; (53):211-2. PubMed ID: 19749335
[TBL] [Abstract][Full Text] [Related]
19. γ-H2AX formation in the urinary bladder of rats treated with two norharman derivatives obtained from o-toluidine and aniline.
Toyoda T; Totsuka Y; Matsushita K; Morikawa T; Miyoshi N; Wakabayashi K; Ogawa K
J Appl Toxicol; 2018 Apr; 38(4):537-543. PubMed ID: 29143974
[TBL] [Abstract][Full Text] [Related]
20. Maternal and developmental toxicity in mice by aminophenylnorharman, formed from norharman and aniline.
Naga T; Yoshimura S; Totsuka Y; Wakabayashi K
Hum Exp Toxicol; 2002 Mar; 21(3):147-51. PubMed ID: 12102540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
